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Tolerance to drugs that affect neural activity is mediated, in part, by adaptive mechanisms that attempt to restore
normal neural excitability. Changes in the expression of ion channel genes are thought to play an important role in
these neural adaptations. The slo gene encodes the pore-forming subunit of BK-type Ca
2þ-activated K
þchannels, which
regulate many aspects of neural activity. Given that induction of slo gene expression plays an important role in the
acquisition of tolerance to sedating drugs, we investigated the molecular mechanism of gene induction. Using
chromatin immunoprecipitation followed by real-time PCR, we show that a single brief sedation with the anesthetic
benzyl alcohol generates a spatiotemporal pattern of histone H4 acetylation across the slo promoter region. Inducing
histone acetylation with a histone deacetylase inhibitor yields a similar pattern of changes in histone acetylation, up-
regulates slo expression, and phenocopies tolerance in a slo-dependent manner. The cAMP response element binding
protein (CREB) is an important transcription factor mediating experience-based neuroadaptations. The slo promoter
region contains putative binding sites for the CREB transcription factor. Chromatin immunoprecipitation assays show
that benzyl alcohol sedation enhances CREB binding within the slo promoter region. Furthermore, activation of a CREB
dominant-negative transgene blocks benzyl alcohol–induced changes in histone acetylation within the slo promoter
region, slo induction, and behavioral tolerance caused by benzyl alcohol sedation. These findings provide unique
evidence that links molecular epigenetic histone modifications and transcriptional induction of an ion channel gene
with a single behavioral event.
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pbio.0050265
Introduction
Drug tolerance can be deﬁned as reduced responsiveness to
an effect of a drug caused by prior exposure to the drug [1].
With regard to recreational drugs, tolerance can cause an
increase in self-administration and thereby speed the user
down the path to addiction and/or to overdose. Most organic
solvents are potent central nervous system depressants that
produce sedation if inhaled or consumed in sufﬁcient
quantities. These properties have led to the use of such
solvents both as anesthetics and as drugs of abuse. We have
used the model system Drosophila melanogaster to study the
neuronal basis of tolerance to organic solvent sedation.
When exposed to a small sedating dose of an organic
solvent, such as benzyl alcohol (BA) or ethanol, Drosophila
acquire rapid tolerance to subsequent solvent sedation. Rapid
tolerance is deﬁned as reduced drug responsiveness caused by
a single prior exposure to the drug. In ﬂies, this manifests
itself as a reduction in the duration of sedation. Changes in
the expression of the slo Ca
2þ-activated K
þ channel gene have
been linked to the production of rapid tolerance. It has been
shown that sedation by a variety of methods induces slo gene
expression in the nervous system, that slo mutations block the
acquisition of behavioral tolerance, and ﬁnally, that trans-
genic induction of slo phenocopies the tolerant phenotype.
Thus, the transcriptional regulation of the slo gene appears to
be of general importance for the production of tolerance to
sedation by various organic solvents [2–4]. We wish to
understand how sedation with organic solvent anesthetics
modulates the slo transcriptional control region. We continue
to use BA as a model organic solvent anesthetic in this
endeavor because it is well tolerated by ﬂies and can be easily
administered.
One of the ﬁrst steps in transcriptional activation is
commonly thought to be the alteration of chromatin
structure. Speciﬁc amino acids in the N-termini of core
histones can be modiﬁed by phosphorylation, acetylation,
methylation, or ubiquitylation [5]. In particular, histone
acetylation is believed to relax chromatin to make the DNA
more accessible for recognition and binding by the tran-
scriptional machinery [6]. Histone acetyltransferases (HATs)
and histone deacetylases (HDACs) are enzymes that modulate
histone acetylation states. Many transcription activators, such
as cAMP-response element binding protein (CREB) binding
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PLoS BIOLOGYprotein (CBP)/p300, have HAT activity, and some tran-
scription repressors, such as Sin3 and RPD3, have HDAC
activity (for review, see [7]).
Recent studies indicate that histone acetylation contributes
to the regulation of neural excitability and synaptic plasticity.
It has been shown to have roles in learning and memory, in
the production of circadian rhythms, and in the response to
seizure, and has been identiﬁed as an important component
underlying cocaine-induced neural plasticity [8–16]. More-
over, the administration of HDAC inhibitors has been shown
to enhance long-term memory, arrest neurodegeneration,
and alter cocaine responses [11,12,17,18].
Transcriptional regulation of the Drosophila slo channel
gene is very complex. It has a 7-kb regulatory region that
includes at least ﬁve transcriptional promoters that mediate
developmental and tissue-speciﬁc gene expression. The two
upstream promoters are neural speciﬁc. Neural expression is
requisite for the acquisition of tolerance to both the
anesthetic BA and to ethanol [2,4,19,20]. Within the slo
transcriptional control region, there exist multiple putative
CREB DNA binding sites. The history of CREB makes it an
attractive candidate for the sedation-mediated activation of
the slo gene and the production of tolerance.
CREB is a key transcription factor involved in regulating
neural plasticity in response to various environmental stimuli
[21]. Activated CREB binds to the cis-regulatory DNA element
cAMP-response element (CRE) to induce target gene ex-
pression. In mammals, CREB has been implicated in the
production of neuronal changes associated with drug
tolerance and addiction. Exposure to addictive drugs,
including opiates, cocaine, nicotine, and ethanol, induces
CREB phosphorylation and CRE-mediated gene expression
in the mouse nucleus accumbens (NAc), a major brain reward
region [22–27]. The elevated CREB function appears to cause
tolerance to and dependence on drugs of abuse. For instance,
increased CREB function in the NAc reduces the sensitivity
of mice to the rewarding effects of cocaine, whereas
decreased CREB function induces cocaine sensitivity [28].
Although the CREB target genes that contribute to these
speciﬁc effects are still not known, it has been shown that
genes that encode some peptide neurotransmitters (NPY and
CRF), neurotrophic factors (BDNF and IGF1), and even
transcription factors (c-Fos) are downstream targets of CREB
in speciﬁc brain regions [29–34]. However, these are thought
to represent only a small subset of the genes regulated by
CREB, and many CREB target genes have not been identiﬁed
[30].
One way that CREB can stimulate transcription is by
recruiting CBP, which is a HAT [35]. By inducing histone
acetylation, CBP makes DNA more accessible to the tran-
scriptional machinery [5]. It has been shown that the histone
acetylation at c-Fos gene promoter, which is mediated by the
recruitment of CBP, contributes to cocaine sensitization [36].
In Drosophila, the cAMP-PKA signaling pathway, a pathway
activating CREB, has been implicated in the development of
drug tolerance. Drosophila carrying a mutation in amnesiac, a
gene encoding a neuropeptide that activates the cAMP
pathway, show increased sensitivity to alcohol [37,38]. Con-
versely, ﬂy mutants with increased PKA activity show
decreased sensitivity to ethanol and cocaine [39].
Here, we show that a sedating dose of BA changes the
chromatin acetylation state of the slo promoter region and
that these changes are linked to increased slo expression,
which produces behavioral tolerance to the sedative effect of
BA. Furthermore, we show that the CREB transcription factor
has an essential role in the production of acetylation changes,
slo induction, and behavioral tolerance to organic solvent
sedation.
Results
Benzyl Alcohol Sedation Dynamically Alters the
Acetylation State of the slo Control Region
A strong link exists between gene induction and the
acetylation of amino-terminal lysines in histone H4 in
promoter regions [6,40,41]. We used the chromatin immuno-
precipitation (ChromIP) assay to detect changes in histone
H4 acetylation across the slo transcriptional control region,
following BA sedation. The antibody used in ChromIP
recognizes histone H4 acetylated at lysines K5, K8, K12, and
K16 in Drosophila and mammals [10,42].
The amount of DNA associated with acetylated histone H4
was quantiﬁed by real-time PCR using primers speciﬁc for
conserved portions of the slo transcriptional control region
(4b, 6b, cre1, 55b, and cre2), the two neural promoters (C0
and C1), and the muscle promoter (C2) (Figure 1A). As a
control, the histone acetylation levels at the promoter of the
Gpdh gene were measured. Neither the Gpdh mRNA abun-
dance nor the acetylation state of the Gpdh promoter was
altered by BA sedation.
No signiﬁcant change in histone acetylation was observed
30 min after BA sedation (Figure 1B). However, we observed a
ﬁnely focused increase in histone H4 acetylation in the
vicinity of 55b 4 h after BA sedation (Figure 1C). This
acetylation change is likely to represent an early step in gene
induction at which increased slo expression is not yet
apparent (Figure 1G). The detection of increased message
abundance may require time for the product to accumulate.
Six hours after BA sedation, we observed a broad acetylation
peak that included both neural promoter C0 and C1 (Figure
1D). This coincided with increased neural expression of slo
(Figure 1H). By 24 h, slo expression appeared to be in decline
(Figure 1I), and the enhanced histone H4 acetylation was
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Author Summary
A startlingly large number of adolescents abuse organic solvent
inhalants, common components of glues, paints, and cleaning
solutions. Our focus is on the molecular basis of tolerance—reduced
response to a drug over time—which promotes increased drug
consumption and accelerates the process of addiction. We use the
fruit fly Drosophila melanogaster as a model system to determine
how the nervous system becomes tolerant to the sedative effects of
organic solvents. Sedating Drosophila with an organic solvent
(benzyl alcohol) increases the expression of the slo K
þchannel gene,
which accelerates recovery from sedation. To elucidate the
molecular mechanics underlying these phenomena, we docu-
mented dynamic changes in a chemical modification (called histone
acetylation) that occurs within the slo regulatory region after
sedation. These changes were mediated by a transcription factor
and are linked to both slo induction and behavioral tolerance.
Increased expression of slo channels is predicted to alter the
signaling properties of neurons. This alteration, we propose, directly
speeds the recovery from sedation.again ﬁnely focused. However, this time, acetylation was
centered over 6b, which is about 300 bp upstream of neural
promoter C1 (Figure 1E). These data indicate that histone
acetylation across the slo transcriptional control region is
dynamically modulated after sedation with the anesthetic BA.
By 48 h, the acetylation level and slo mRNA level have
returned to the pretreatment level (Figure 1F and 1J).
Increased Histone Acetylation Induces slo Gene
Expression and Mimics Tolerance
To determine whether the observed changes in histone
acetylation are related to slo induction and to the acquisition
of BA sedation–induced BA tolerance, we used sodium
butyrate to induce histone acetylation. Sodium butyrate is
an extremely well-tolerated, nonspeciﬁc HDAC inhibitor that
has been used to artiﬁcially induce histone acetylation both
in mammals and insects [11,18,43–46]. Newly eclosed wild-
type Canton S ﬂies were split into two groups that differed
only in the presence or absence of sodium butyrate in their
food. Flies in the experimental group were fed food that
contained 0.05 M sodium butyrate, and control group ﬂies
were fed food that lacked sodium butyrate. After 3 d, ﬂy heads
were collected, and ChromIP assays were performed to
determine the acetylation state of histone H4. Overall histone
H4 acetylation levels, expressed as the ratio of DNA
associated with the acetylated chromatin to input DNA, were
increased in the experimental group. As previously reported
[18,42,43], sodium butyrate administration increased the
global histone H4 acetylation level by approximately 30%
(Figure 2A). The increase in acetylation is not uniform across
the slo control region. Statistically signiﬁcant increases in
acetylation were observed only at region 6b (Figure 2B).
Sodium butyrate, a nonspeciﬁc HDAC inhibitor, alters
acetylation at the slo promoter region because it raises global
histone acetylation levels. However, BA does not behave as a
nonspeciﬁc enhancer of histone acetylation, because sedation
with BA does not enhance global acetylation levels (Figure
2A).
Our working hypothesis was that BA sedation increases
histone acetylation, which in turn stimulates slo expression,
and that this increase in slo expression leads to behavioral
drug tolerance. In support of this hypothesis, we observed
that sodium butyrate consumption both induced slo expres-
Figure 1. Benzyl Alcohol Sedation Causes Changes in the Acetylation
Pattern of the slo Control Region
(A) Map of the slo transcription control region. The slo gene has at least
five tissue-specific promoters. The transcriptional start sites for these
promoters are identified by the arrows. Closed boxes on the line
represent exons. The row of boxes below the line represent evolutio-
narily conserved regions assayed in the ChromIP assay.
(B–F) Acetylation state of histone H4 surveyed after BA sedation as
determined by ChromIP and real-time PCR. Fold change is the ratio of
acetylation levels obtained for BA sedated animals and mock-sedated
age-matched controls. Bar graphs represent the mean 6 SEM for three
to six independent experiments. Statistical significance was determined
by one-way ANOVA with Dunnett’s comparison (n¼3–6, a single asterisk
[*] indicates p , 0.05, and double asterisks [**] indicate p , 0.01 with
respect to Gpdh).
(B) There is no significant change in histone H4 acetylation 30 min after
BA sedation.
(C) Four hours after BA sedation, there is a significant increase in
acetylation at conserved region 55b.
(D) Six hours after BA sedation, hyperacetylation was observed over both
neural promoters and 6b.
(E) Twenty-four hours after BA sedation, the acetylation state of histone
H4 has changed. Peak acetylation levels are centered at the conserved 6b
region, and the level of acetylation of other regions has returned to
control levels.
(F) By 48 h, acetylation level across the slo promoter region has returned
to baseline levels (no change relative to the mock-treated animals).
(G–J) Relative slo mRNA abundance measured by real-time RT-PCR (using
primers that recognize the transcripts produced from both neural
promoters, C0 and C1) at 4, 6, 24, and 48 h, respectively, after BA
sedation. Significance was determined using the Student t-test (n ¼ 4; a
single asterisk [*] indicates p , 0.05).
doi:10.1371/journal.pbio.0050265.g001
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Epigenetic Changes Produce Drug Tolerancesion and phenocopied BA tolerance. As shown in Figure 3A,
sedation with BA caused a 50% increase in neural slo mRNA
abundance 6 h after sedation, whereas the consumption of
sodium butyrate–laced food produced a 2-fold induction in
neural slo messenger abundance (Figure 3A).
A typical example of BA-induced behavioral tolerance is
shown in Figure 3B. As previously described [2], ﬂies recover
more rapidly from their second sedation than from their ﬁrst
sedation. Figure 3C shows that the ﬂies fed food laced with
sodium butyrate exhibited a tolerance-like phenotype.
Importantly, we observed that BA sedation of sodium
butyrate–fed ﬂies did not further enhance the expression
level of slo (Figure 3A) or the relative degree of BA resistance
(Figure 3D). This observation is consistent with the proposal
that BA and sodium butyrate affect these characteristics
through a common, saturable pathway.
Sodium Butyrate–Induced Resistance Requires a
Functional slo Gene
Sodium butyrate increases the level of acetylated histones
globally [42,43]. Therefore, the tolerance-like phenotype
caused by sodium butyrate consumption might be unrelated
to the slo gene. To exclude this possibility, we determined
whether slo mutations interfere with the capacity to acquire
tolerance. The slo
4 allele is a loss-of-function slo mutation. It
has been characterized as a null mutation genetically,
molecularly, behaviorally, and electrophysiologically [47–49].
The slo
4 homozygous ﬂies show subtle behavioral differences
from wild-type ﬂies, one of which is that they do not acquire
tolerance following a single BA or ethanol sedation [2,3].
To test whether sodium butyrate–induced BA resistance
was related to the slo gene, we asked whether the slo
4 mutation
could block the capacity to acquire sodium butyrate–induced
BA resistance. The consumption of sodium butyrate did not
induce the tolerance-like phenotype in slo
4 homozygotes, but
the wild-type Canton S ﬂies, raised and tested under the same
conditions, displayed the tolerance-like phenotype (Figure 4A
and 4B). This indicates that the induction of BA resistance by
sodium butyrate is dependent on a functional slo gene.
Previous studies have indicated that only neural expression
of slo is involved in the production of BA tolerance [2].
Therefore, we asked whether sodium butyrate–induced BA
resistance could be blocked merely by eliminating neural
expression of slo. The ash2
18 mutant chromosome carries a
deletion that removes the two neural promoters of slo, but not
the promoters responsible for expression in muscle, tracheal
cell, or epithelia tissues. The deletion is a recessive lethal
because it removes the neighboring gene [2,49,50]. Therefore,
we used ash2
18/slo
4 transheterozygotes as a way to speciﬁcally
eliminate slo expression in the nervous system. As shown in
Figure 4C, the elimination of slo expression in the central
nervous system prevents the induction of BA resistance by
sodium butyrate. Figure 4D shows that sodium butyrate–
induced BA resistance is a recessive phenotype of the slo
4
mutation.
Benzyl Alcohol Sedation Induces dCREB2 Occupancy in
the slo Transcriptional Control Region
In Drosophila, two CREB family genes have been identiﬁed,
dCREB-A and dCREB2 (also called dCREB-B). dCREB-A is
weakly expressed in the adult brain [51] and has not yet
been linked to behavioral phenotypes. The dCREB2 gene is
most similar to mammalian CREB and CREM genes and is
considered to be the Drosophila homolog of these genes
[52].
dCREB2 is expressed in the adult brain, and has been
implicated in the formation of learning, memory, and
circadian behavior [52–54]. As with other transcription
factors, CREB has functionally independent activation (KID)
and DNA binding (bZIP) domains. In Drosophila, it has been
shown that the KID domain of most dCREB2 proteins exists
in a phosphorylated active state. As a result, in Drosophila,
CREB activity has been postulated to be controlled at the
level of DNA binding to its DNA elements [55]. Two putative
CRE sites were identiﬁed close to 55b in the slo control region
by sequence analysis. Furthermore, the highly conserved 55b
element contains an AP-1 binding site motif. Both AP-1 and
CREB belong to the b-ZIP family of transcription factors
which share a similar DNA binding motif, the leucine
Figure 2. The HDAC Inhibitor Sodium Butyrate Enhances Histone
Acetylation Levels
(A) Sodium butyrate (SB) increases the global level of histone H4
acetylation. Control represents the global histone H4 acetylation level in
flies fed normal food; 0.4% BA represents the level of histone H4
acetylation in flies sedated with 0.4% BA; and 0.05M SB represents the
global histone H4 acetylation level in animals fed food supplemented
with 0.05 M sodium butyrate (n ¼ 4; a single asterisk [*] indicates p ,
0.05, Student t-test). The H4 acetylation level is expressed as the percent
ratio of the amount of DNA coimmunoprecipitated by anti-acetylated
histone H4 antibody versus the total amount of input DNA used in the
immunoprecipitation.
(B) ChromIP assays indicate that the consumption of food containing
0.05 M sodium butyrate induced histone H4 acetylation specifically at
the evolutionarily conserved 6b sequence of the slo transcriptional
control region. Bar graphs represent the mean 6 SEM for three to six
independent experiments. Statistical significance was determined by
one-way ANOVA with the Dunnett comparison (n¼3–6; a single asterisk
[*] indicates p , 0.05, with respect to cyclophilin 1).
doi:10.1371/journal.pbio.0050265.g002
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similar to the CREB response element, with only one base
difference (CRE sequence: TGACGTCA). Both CREB and
AP-1 can induce local histone acetylation by recruiting CBP
HAT [35].
We performed the ChromIP assay using an anti-CREB
antibody that recognizes the Drosophila dCREB2 DNA binding
domain (Santa Cruz Biotechnology, http://www.scbt.com). We
determined the relative occupancy of dCREB2 protein within
the slo promoter region both before and after drug sedation.
The data indicate a clear drug-induced increase in CREB
binding at and around the 55b region (Figure 5).
Induction of a CREB Dominant-Negative Transgene Blocks
Histone Acetylation within the slo Promoter Region
As previously described, BA sedation altered histone H4
acetylation across the slo promoter region. Shortly after
sedation, acetylation was induced at 55b; a conserved site that
is ﬂanked by two CRE sites. It has been shown that binding of
CREB at CRE sites can induce local histone acetylation by
recruiting CBP and thereby activate gene expression [13,56].
To test whether the early acetylation peak over 55b within the
slo control region is caused by the recruitment of CREB and
CBP, we asked whether a dominant-negative CREB tran-
scription factor could prevent the early histone acetylation
peak at 55b. To do this, we transgenically expressed the
repressor isoform of the dCREB2.
As in mammals, the dCREB2 transcript is alternatively
spliced. The dCREB2a splice variant acts as a transcriptional
activator, whereas the dCREB2b isoform has repressor
activity [53]. A dominant-nega t i v et r a n s g e n i cl i n et h a t
expresses dCREB2b under the control of a hsp70 heat-shock
promoter (hs-dCREB2b) provided a way to inducibly inhibit
CREB-mediated gene activation [54,57]. Previous studies have
shown that a brief heat pulse (37 8C for 30 min) induces the
transgene (hs-dCREB2b) and that elevated protein levels
persist up to 24 h [54].
In this study, the dCREB2b transgene was induced, and
histone acetylation levels were measured after BA sedation.
These acetylation levels were compared to those from ﬂies of
the same genotype in which the transgene had not been
activated. We observed that the induction of dominant-
negative CREB by a brief heat pulse 1 h prior to BA sedation
eliminated the histone acetylation peak around 55b (Figure
6). The same heat shock protocol has no effect on the histone
acetylation changes at 55b in wild-type Canton S ﬂies. This
Figure 3. Sodium Butyrate Causes a Tolerant-Like Phenotype and Induces slo Levels
(A) slo mRNA levels in Canton S (CS) heads were measured by real-time RT-PCR with C1 primers that only amplify neural slo transcripts. Six hours after
BA sedation, slo mRNA increased approximately 50% compared with nonsedated flies. Sodium butyrate consumption induced slo expression about 2-
fold. BA sedation of sodium butyrate–fed flies did not further increase slo mRNA abundance (n ¼ 4; p , 0.05, Student t-test).
(B) A tolerance assay showed that flies sedated with BA recover more rapidly after their second sedation than after their first sedation (24 h between
sedations). Shown are recovery curves of a population of age-matched females after their first (blue) and their second (red) sedation. Plotted are the
percentage of flies that have returned to wall climbing. Counts were made at 30-s intervals. The inset shows that the sedated population has higher
neural expression of slo mRNA as measured by real-time PCR.
(C) The curves show the recovery from BA sedation of flies that consumed food containing 0.05 M sodium butyrate (0.05MSB; red) and the recovery of
flies that consumed the same food without sodium butyrate (0MSB;blue). The consumption of the HDAC inhibitor, sodium butyrate, mimics the
tolerance phenotype shown in (B). The inset shows that neural expression of slo is increased by sodium butyrate consumption relative to the matched
control.
(D) Flies that had been fed sodium butyrate were sedated once (blue) or twice (red, 24 h between sedation) with BA. Both populations recovered from
sedation at the same rate. The inset shows the mRNA expression level from slo. Notice that BA sedation plus sodium butyrate does not enhance slo
expression more than sodium butyrate consumption alone. For all insets, slo mRNA abundance has been normalized to the cyclophilin 1 internal control.
For all plots, the significant differences between curves was determined by log-rank test (for [B], [C], and [D], n¼45; a single asterisk [*] indicates p ,
0.05, and double asterisks [**] indicate p , 0.01).
doi:10.1371/journal.pbio.0050265.g003
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peak requires the binding of CREB to CREs at slo transcrip-
tional control region.
Activation of a Dominant-Negative CREB Transgene
Reduces Benzyl Alcohol Sedation–Induced slo Expression
The previous data indicate that CREB activity is involved
in the drug sedation–induced hyperacetylation within the slo
promoter region. Acetylation changes have been linked to
slo induction. Therefore, we asked whether dominant-
negative CREB could interfere with the induction of slo
after drug sedation. Both hs-dCREB2b transgenic females and
wild-type CS females were subjected to 37 8C incubation for
30 min, 1 h before BA exposure, and the relative slo
messenger levels were measured 6 h after drug exposure by
real-time reverse transcriptase PCR (RT-PCR). We observed
that induction of the dominant-negative CREB transgene 1 h
prior to BA sedation suppressed slo induction (Figure 7). The
same heat shock protocol did not suppress slo induction in
wild-type CS ﬂies following BA sedation. This result suggests
that disruption of early histone acetylation pattern by
inhibiting CREB activity blocks BA sedation–induced slo
up-regulation.
Induction of a Dominant-Negative CREB Transgene
Prevents the Acquisition of Tolerance
The data above indicate that overexpression of dominant-
negative dCREB2 can block drug-induced acetylation in the
slo promoter region and the up-regulation of slo expression.
Because slo induction appears causally linked to the produc-
tion of tolerance in this behavioral paradigm, the activation
of the hs-dCREB2b transgene should also block the acquisition
of tolerance.
To test this idea, we examined induced and uninduced hs-
dCREB2b transgenic ﬂies for their capacity to acquire
tolerance. Uninduced hs-dCREB2b ﬂies acquired robust
tolerance (Figure 8A). However, induction of dCREB2b
transgene by heat shock 1 h before the ﬁrst BA sedation
completely blocked the acquisition of tolerance (Figure 8B).
This occurred without a change in the initial sensitivity of
ﬂies to drug sedation (Figure 8C). The heat-activation
protocol did not alter the relative magnitude of tolerance
acquired by a wild-type Canton S stock (Figure 8D and 8E).
These data indicate that CREB transcription factor activity is
important for the acquisition of rapid tolerance in ﬂies.
Discussion
It has become clear that drug-induced changes in gene
expression play an important role in the pharmacodynamic
response to drugs of abuse. Epigenetic modiﬁcations to
promoter regions are rapidly emerging as an important
mechanism for producing these changes [11,58]. Epigenetics
refers to DNA and chromatin modiﬁcations that inﬂuence
chromatin structure and change the state of gene expression
without altering the nucleotide sequence [59]. Hyperacetyla-
tion of histone H4 has been linked to neural gene activation
in activity-dependent signaling pathways and in synaptic
Figure 4. The Sodium Butyrate–Induced Benzyl Alcohol Resistance Phenotype Is Dependent upon a Functional slo Gene
(A) The consumption of sodium butyrate causes wild-type Canton S (CS) flies to acquire BA resistance. The label 0MSB indicates flies fed normal food,
and 0.05MSB represents flies fed food supplemented with 0.05 M sodium butyrate.
(B) Sodium butyrate consumption does not cause slo
4 homozygotes to acquire BA resistance.
(C) ash2
18/slo
4 transheterozygotes also did not show sodium butyrate–induced BA resistance.
(D) However, slo
4/þ flies show a sodium butyrate–inducible resistance to BA sedation. The period of sedation in (A) and (B) versus (C) and (D) is
somewhat different. This is likely the product of slight differences in the dose of the drug because the (A–B) pair and the (C–D) pair were performed on
different days. Significance between recovery curves was determined by the log-rank test (n ¼ 45; a single asterisk [*] indicates p , 0.05, and double
asterisks [**] indicate p , 0.01).
doi:10.1371/journal.pbio.0050265.g004
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neural slo expression in a dose-dependent manner, and
increased slo gene expression has been implicated in the
production of rapid tolerance to both ethanol and BA [2–4].
An increase in histone acetylation is generally accepted to
make DNA sequences more available to transcription factors.
Hyperacetylation at one site might beget subsequent hyper-
acetylation at a second site. That is, the activity of one
transcription factor could modify an area to facilitate the
binding of additional transcription factors. The action of
these factors may continue to further modify the region. We
show that sedation with the anesthetic BA produces a speciﬁc
spatiotemporal pattern of histone H4 acetylation across the
slo promoter region. These epigenetic changes are correlated
with changes in slo transcription and with the development of
drug tolerance, and are thought to be the molecular
footprints of a regulatory cascade that is initiated by BA
sedation.
The acetylation spike at 55b occurs immediately prior to
the induction of slo expression and may make available
speciﬁc sequences that are necessary to activate the upstream
neural promoters. Two hours later, we recorded the greatest
increase in slo expression and an increase in acetylation that
involves most of the slo neural promoter region. The process
of transcription itself can enhance acetylation, and therefore,
this broad boost in acetylation may be a direct by-product of
transcription [60]. Finally, at 24 h post BA sedation, there is
an isolated acetylation spike at 6b, and slo expression remains
elevated (albeit slightly less elevated than at 6 h post
sedation). This may mean that increased accessibility of 6b
is required to maintain slo induction. We propose that this
dynamic pattern of hyperacetylation represents an unfolding
regulatory program that leads to a transient and self-limiting
boost in slo channel expression.
We used the HDAC inhibitor sodium butyrate to artiﬁcially
induce histone acetylation in the genome. We asked whether
as i m p l ec h a n g ei na c e t y l a t i o nw o u l di n d u c eslo gene
expression and whether it could also produce a tolerance-
like phenotype. We observed that sodium butyrate consump-
tion induced slo expression and phenocopied the BA
sedation–induced tolerance phenotype. In various prepara-
tions, sodium butyrate has been shown to enhance histone
acetylation and to induce expression of a small fraction of the
genes in the eukaryotic genome (estimates range from 1% to
7%) [45,61,62]. Therefore, our result would be irrelevant if we
could not directly link sodium butyrate–induced BA resist-
ance to slo, and demonstrate other similarities to the effects
of BA sedation. Using slo null mutations, we were able to show
Figure 6. Induction of CREB Dominant-Negative Transgene Blocks
Acetylation Changes Produced by Benzyl Alcohol Sedation
The histone H4 acetylation profile across the slo control region was
assayed by ChromIP and real-time PCR 4 h after BA sedation. Fold
change is the ratio of H4 acetylation of sedated animals to mock-sedated
control animals.
(A) Without heat induction (NoHS; blue bars) of the dominant-negative
CREB transgene (hs-dCREB2b), there are significant changes in H4
acetylation at cre1, 55b, and cre2. These changes in H4 acetylation
were blocked by heat-pulse induction of hs-dCREB2b (HS; red bars) 1 h
before BA sedation.
(B) BA sedation of the Canton S (CS) stock (wild-type, nontransgenic)
produces the same acetylation profile regardless of whether the stock
had also been heat treated (HS; red bars) or not heat treated (NoHS; blue
bars). The graph depicts data from four independent experiments (mean
6 SEM). Statistical significance refers to the difference between the
NoHS and HS treatments, and was determined by two-way ANOVA (n ¼
4; a single asterisk [*] indicates p , 0.05, and double asterisks [**]
indicate p , 0.01).
doi:10.1371/journal.pbio.0050265.g006
Figure 5. CREB Occupancy Is Enhanced by Sedation with Benzyl Alcohol
Binding of CREB across the slo control region was measured 4 h after BA
sedation with the ChromIP assay using an antibody against the CREB
bZIP domain. Signals obtained from PCR amplification of immunopre-
cipitated chromatin were normalized to the signal from input chromatin.
Increased CREB occupancy was observed at and between the two
putative CRE sites called cre1 and cre2. Significance was determined by
two-way ANOVA (n ¼ 3; a single asterisk [*] indicates p , 0.05).
doi:10.1371/journal.pbio.0050265.g005
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Epigenetic Changes Produce Drug Tolerancethat the capacity of sodium butyrate to phenocopy tolerance
is dependent on slo expression in the nervous system, as is
rapid tolerance induced by BA or ethanol sedation [2,3]. In
addition, BA sedation of sodium butyrate–fed ﬂies did not
further enhance resistance, suggesting that both act through a
common, saturable pathway. Finally, we were surprised to
ﬁnd some similarity between sodium butyrate and BA
sedation upon the pattern of acetylation on the slo tran-
scription control region. Sodium butyrate also caused hyper-
acetylation at the conserved 6b sequence, but did not
detectably change acetylation at C1, cre1, or 55b sites. This
mimics the acetylation pattern observed 24 h after BA
sedation. Since sodium butyrate inhibits HDAC activity, the
enhancement of 6b acetylation by sodium butyrate suggests
that it has inhibited an HDAC that is chronically positioned
near or at the 6b site. The simplest interpretation is that
enhanced availability of 6b permits slo induction.
Both 55b and 6b are non–promoter-containing DNA
sequences that were originally identiﬁed because of their
conservation between two Drosophila species [19,63]. Con-
servation alone is a strong indicator that these sequences
have important roles in the regulation of the slo gene. Figure
9 shows that they are highly conserved across at least eight
Drosophila species.
Two putative CREB binding sites are located close to 55b.
The cre1 site is TGACGAA and cre2 is TGACGTAA. The cre1
site matches the canonical CRE motif, whereas cre2 differs in
a single nucleotide. Both include the ﬁrst ﬁve bases of the
consensus CRE sites (TGACG), which are sufﬁcient for CREB-
mediated transcription [64]. Furthermore, in 55b, there is a
putative AP-1 site (TGATTCA) which differs in two nucleo-
tides from the canonical CRE site. AP-1 and CREB carry
similar dimerization and DNA binding b-ZIP domains.
Studies suggest AP-1 and CREB can form cross-family
heterodimers and share same consensus DNA binding
elements [65].
The AP-1 and CREB transcription factors have been
implicated in the neural response to abused drugs. AP-1
transcription factor complexes are dimers formed from the
Jun and Fos family of transcription factors. Acute admin-
istration of certain abused drugs causes complex changes in
the pattern of the Fos family members [27,66–68]. These
changes affect drug responsiveness and are thought to
underlie long-lasting sensitization to cocaine in mammals
[67]. The modulation of CREB activity has been linked to
drug tolerance and dependence and many other neural
responses that can all be considered to be forms of neural
plasticity [67,69–71].
Both AP-1 and CREB can stimulate gene expression by
recruiting cofactor CBP, which helps to position the basal
transcriptional machinery [35,72]. CBP is a HAT that through
histone acetylation causes local decondensation of chromatin
[35]. We postulated that AP-1 or CREB might be involved in
acetylation at 55b. ChromIP experiments indicated that AP-1
did not bind the slo promoter region (unpublished data).
However, ChromIP did show that CREB bound in this region
and that drug sedation enhanced CREB occupancy. We
further implicated CREB, in drug-mediated slo expression
and behavioral tolerance, by showing that a dominant-
negative CREB transcription factor could block hyperacety-
lation surrounding 55b, the induction of slo, and behavioral
tolerance caused by BA sedation.
These data suggest a chain of events for the regulation of slo
in response to BA sedation. That is; drug sedation activates
the CREB signaling pathway. CREB binds the CRE sites
ﬂanking 55b and perhaps within 55b itself, and then recruits
the CBP HAT to acetylate histones in the neighborhood of
55b. This makes sequences at 55b available for binding by
factors that lead to further modiﬁcations and result in the
inhibition of the HDAC positioned at 6b. Inhibition of this
HDAC augments 6b acetylation, making it available for
binding by a factor (perhaps HSF, Figure 9) that directly
stimulates expression from the two neighboring neural
promoters. Blockage of any of these events would interfere
with the drug-induced slo expression and animals’ ability to
develop tolerance. Although other more complex models are
possible, this simple model will eventually be testable as new
tools become available, and is useful for organizing ideas
about how slo senses and responds to drug sedation.
We have previously postulated that the induction of slo is a
homeostatic response that acts to reverse decreased neural
excitability associated with sedation by the drug BA.
Anesthesia induces slo gene expression, and by itself, the
induction of this channel gene phenocopies tolerance [2].
Our data are consistent with the idea that increased BK
channel expression reduced the duration of sedation caused
by BA and produced a tolerance-like phenotype. This is an
unusual role to postulate for a K
þ channel. Certainly, in some
preparations, increased BK channel activity reduces neural
excitability [73–75]. However, in other preparations, BK
Figure 7. Activation of the Dominant-Negative CREB Transgene Blocks
Benzyl Alcohol Sedation–Induced slo Expression
Neuronal slo expression in hs-dCREB2b and Canton S (CS) wild-type fly
heads were measured by real-time RT-PCR using C1 primers that are
specific for neural slo transcripts. Blue bars represent the slo expression
level in animals that were not sedated. Red bars show the level of slo
mRNA expression 6 h after sedation. The hs-dCREB2b line shows robust
slo induction after sedation if the transgene is not induced (RT hs-
dCREB2b). Induction of the hs-dCREB2b transgene (37C hs-dCREB2b)
reduces induction of slo by sedation. The transgene was induced with a
30 min/37 8C heat pulse 1 h before BA sedation. This treatment protocol
does not affect the relative levels of slo expression in nontransgenic flies.
Nontransgenic wild-type Canton S flies have similar levels of slo
expression when they have been maintained at room temperature (RT
CS) and when they have been subjected to the heat-induction protocol
(37C CS). The relative slo mRNA levels were shown as ratio of messenger
levels of slo to messenger levels of the cyclophilin 1 gene, which
functions as a internal control (n ¼ 4; a single asterisk [*] indicates p ,
0.05, Student t-test). NS, not significant.
doi:10.1371/journal.pbio.0050265.g007
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Epigenetic Changes Produce Drug Tolerancechannel activity has been positively correlated with neural
excitability [76–80]. It has been proposed that an increase in
BK channel activity limits the instantaneous response of the
cell, but augments the capacity for repetitive neural activity
by reducing the neural refractory period [76,77]. The
refractory period is the time that must elapse before the
neuron can ﬁre again.
Neural pharmacodynamic tolerance to any drug is likely to
involve many components [81–84]; however, the slo gene is
uniquely positioned to be a homeostatic regulator of neural
excitability. The encoded channel has the highest conduc-
tance of any neural ion channel, thus small changes in its
density can have a large inﬂuence on membrane excitability.
In conclusion, we propose that in ﬂies, BA sedation causes
CREB-mediated epigenetic changes in the slo control region
that result in an increase in slo expression, which signiﬁcantly
enhances the excitability of the nervous system to help
produce the tolerance phenotype.
Materials and Methods
Fly stocks. Drosophila stocks were Canton S (wild type), slo
4, ash2
18/
slo
4, and the hs-dCREB2b. All ﬂy stocks were raised on standard
cornmeal agar medium (12/12-h light/dark cycle). Newly eclosed ﬂies
collected over a 1- to 2-d interval were studied 4–5 d after eclosion.
The hs-dCREB2b transgene expresses a dCREB2b cDNA from a hsp70
promoter [54].
Benzyl alcohol exposure and sodium butyrate consumption. Age-
matched female Canton S ﬂies were divided into six groups of 15.
Three groups were sedated with 0.4% BA, and three were mock
sedated as previously described [2]. Sodium butyrate (0.05 M, 99%
purity; Fisher Scientiﬁc, https://www.ﬁshersci.com) in food was fed to
1- to 2-d-old ﬂies for 3 d. Controls were fed unadulterated food.
Tolerance assay. Tolerance was measured as described [2]. In the
ﬁrst exposure, three experimental groups were exposed to 0.4%
benzyl alcohol until sedation, and three control groups were mock
sedated in parallel. Twenty-four hours later, all groups were sedated
with BA, then transferred to an anesthetic-free environment, and
recovered ﬂies were counted every 30 s. Flies were scored as
recovered when they resumed climbing. The log-rank test was used
to determine signiﬁcance between curves [85]. However, error bars
represent the standard error of the mean (SEM) for each point.
Figure 8. Induction of the Dominant-Negative CREB Transgene Prevents the Acquisition of Tolerance
Shown are recovery curves of a populations of age-matched females after their first (blue) and their second (red) BA sedation. Plotted are the
percentage of flies that have returned to wall climbing. Counts were made at 30-s intervals.
(A) hs-dCREB2b transgenic flies developed rapid tolerance if the transgene is not induced (no heat shock [noHS]).
(B) Induction of the dCREB2b transgene by a brief heat shock (37 8C, 30 min; HS) 1 h before the first sedation blocked the acquisition of rapid tolerance,
which is measured 24 h after initial drug sedation.
(C) Heat shock had no effect on the wake-up time of hs-dCREB2b transgenic flies from their first sedation.
(D and E) Wild-type Canton S control group developed rapid tolerance after first sedation regardless of whether they were subjected to the heat
protocol.
(F) Heat shock by itself had no effect on the wake-up time of CS flies from their first sedation. Significance between recovery curves was determined by
log-rank test (n ¼ 45; a single asterisk [*] indicates p , 0.05).
doi:10.1371/journal.pbio.0050265.g008
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Epigenetic Changes Produce Drug ToleranceChromatin immunoprecipitation assay. About 1,500 wild-type ﬂies
were either BA sedated or mock sedated for 5 min and then were
allowed to recover in a BA-free environment [2]. Thirty minutes, and
4, 6, 24, and 48 h after sedation, ﬂies were collected, frozen in liquid
nitrogen, and vortex decapitated, and then heads were collected by
sieving. Heads were cross-linked with 2% formaldehyde for 5 min,
and chromatin was solubilized and sonicated on ice 6330 s, followed
by 1 min cooling on ice to produce fragments of approximately 600
bp with a sonic Dismembrator 250 (Fisher Scientiﬁc) as described by
Orlando et al. [86]. Sheared soluble chromatin was stored at  80 8C.
The ChromIP assay was performed as described (ChIP kit # 17–295;
Upstate Biotechnology, http://www.upstate.com) with minor modiﬁ-
cations. One milliliter of soluble chromatin (1 mg/ml) was adjusted to
RIPA buffer and then precleared with 50-ll salmon sperm DNA/
protein A agarose slurry for 1 h at 4 8C to reduce nonspeciﬁc binding.
Ten percent of the preimmunoprecipitation lysate (100 ll) was held
back and used to determine the input of DNA. The input-level
control was processed with the eluted immunoprecipitations (IPs),
beginning with the cross-linking reversal step. The polyclonal
antibody (catalog # 06–866; Upstate Biotechnology) against acetylated
H4 at K5, K8, K12, and K16, and anti-CREB antibody (sc-186; Santa
Cruz Biotechnology) were used at 1:200 dilution. Five microliters of
antibody were added to each sample in 1-ml RIPA buffer and
incubated overnight at 4 8C with gentle mixing. Immunocomplexes
were recovered by adding 80 ll of the salmon sperm DNA/protein A
agarose beads, incubating for 3 h at 4 8C with rotation. The beads
were sequentially washed three times in RIPA (140 mM NaCl, 1 mM
EDTA, 10 mM Tris-HCl [pH 8], 1% Triton X-100, 0.1% SDS, 0.1%
sodium deoxycolate), twice in high-salt buffer, once in LiCl buffer,
and twice in TE buffer, 10 min each. The cross-linking between
histones and DNA was reversed by incubating at 65 8C overnight, and
DNA fragments were puriﬁed with phenol-chloroform extraction
followed by acid ethanol precipitation. ChromIP assays were
performed more than three times with independent tissue samples.
Real-time PCR was performed using the ABI SYBR Green PCR
protocol (Applied Biosystems, http://www.appliedbiosystems.com).
Within the slo transcriptional control region (Figure 1A), primers
were designed to amplify approximately 200-bp fragments at the two
neural promoters (C0 and C1), at one muscle promoter (C2), and at
six evolutionarily conserved areas (4b, 6b, cre1, 55b, S2, and cre2). As
internal controls, we used Gpdh (Glycerol-3-phosphate dehydrogen-
ase) and Cyp1 (cyclophilin 1). Primers sets are: C0 (59-ATCGAAC-
GAAGCGTCCAG-39,5 9-CGACGCGCTCAAACG-39), 4b (59-
GACCCGATGATAAAGTCGATGT-39,5 9-GCCAGTGACTGACTGA-
CACACA-39), 6b (59-CCAGCAGCAATTGTGAGAAA-39,5 9-CGAAG-
CAGACTTGAAAGCAA-39), C1 (59-ACAAACCAAAACGCACAATG-
39,5 9-AATGGATGAAGGACTGGGAGT-39), cre1 (59-GATGG-
GAAAGCGAAAAGACAT-39,5 9-CATGTCCGTCAAAGCGAAAC-39),
55b (59-TACCCAATTGAATTCGCCTTGTCTT-39,5 9-
CCCACTCTCCGGCCATCTCT-39), S2 (59-CATTGCTATCCCTTCC-
CATC-39,5 9-ATGCAATGAAGCGAAGAACC-39), C2 (59-GCACTC-
GACTGCACTTGAAC-39,5 9-AATGAAAAAGTTCTCTCTGTGCAT-
39), cre2 (59-TGGATTGCGACCGAGTGTCT-39,5 9-ATCAATACGA-
TAACTGGCGGAAACA-39), Gpdh (59-GCATACCTT-
GATCTTGGCCGT-39,5 9-GCCCTGAAAAGTGCAAGAAG-39), and
Cyp1 (59-TCTGCGTATGTGTGGCTCAT-39,5 9-TACAGAACTCGCG-
CATTCAC-39).
All amplicons have differences in standard-curve ampliﬁcation
slopes of less than 0.1. Melting curves were used to detect nonspeciﬁc
ampliﬁcation. Ampliﬁcations were run in triplicate, and the changes
on histone H4 acetylation were calculated by the DDCT method. Fold
enrichment over control equals 2^(CT
Input –C T
IP)experiment/2^(CT
input
–C T
IP)control. The entire protocol was repeated in triplicate a
minimum of three times, and the mean and SEM were calculated.
Signiﬁcance was determined by one-way ANOVA.
For ChromIP to measure CREB binding, all real-time PCR
measurement values were normalized to input DNA in both the
BA-sedated and mock-sedated control. The amount of DNA
recovered in the IP was expressed as the ratio of input DNA with
the equation: IP/input ¼ 2^(Ct
input   Ct
IP). The entire protocol has
been repeated in triplicate, and the mean and SEM calculated.
Signiﬁcance was determined with the two-way ANOVA.
Global acetylation assay. Chromatin from cross-linked ﬂy heads
was sonicated and immunoprecipitated with anti-H4 antibody as
described above. DNA coimmunoprecipitated with acetylated histone
H4 and input DNA were puriﬁed by reverse cross-linking followed by
phenol-chloroform extraction. DNA was then quantiﬁed in a Nano-
Drop spectophotometer (NanoDrop Technologies, http://www.
nanodrop.com). Global histone H4 acetylation levels were expressed
as the ratio of the amount of DNA associated with the acetylated
chromatin to input DNA. The entire protocol has been repeated four
times, and the mean and SEM calculated. Signiﬁcance was deter-
mined with the Student t-test.
Quantitative RT-PCR analysis. RNA was isolated from heads using
a single-step RNA isolation protocol as described previously [2] and
quantiﬁed (NanoDrop Technologies). Reverse transcription and real-
time RT-PCR were performed in triplicate with slo exon C1-speciﬁc
primers, which only amplify transcripts from the neural promoters,
and cyclophilin 1 primers as described [4]. Fold change was calculated
using the standard-curve method (Applied Biosystems manual).
Signiﬁcance was calculated using the Student t-test.
Heat-induction protocol for the HS-dCREB2b transgene dCREB
repressor (dCREB2b) transgene was induced at 37 8C for 30 min in a
humidiﬁed incubator as described [54]. Immediately after heat shock,
Figure 9. Genomic Sequence Conservation of 55b and 6b across Multiple Species of Drosophila
(A) Alignment of the 55b box [63] and (B) the 6b box [19] across eight Drosophila species. Areas of highest identity (80%) are boxed, and black bars
below the line denote transcription factor binding motifs that are conserved in these species.
Drosophila species: ana, D. ananassae; hyd, D. hydei; mel, D. melanogaster; moj, D. mojavensis; mul, D. mulleri; pse, D. pseudoobscura; vir, D. virilis; and yak,
D. yakuba.
Transcription factor binding sites: AP-1, Activator Protein-1; Bcd, Bicoid; BRC, Broad Complex; CF-1, Chorion Factor 1; CROC, Crocodile; DL, Dorsal; Elf-1,
Element I-binding activity; En, Engrailed; Ftz, Fushi Tarazu; GCM, Glial Cells Missing; HSF, Heat Shock Motif; mtTFA, Mitochondrial Factor A; and Sry-Beta,
Serendipity Beta.
doi:10.1371/journal.pbio.0050265.g009
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Epigenetic Changes Produce Drug Toleranceﬂies were sedated with CO2 to reduce the net effect of heat on the
neural activity. Half an hour later, ﬂies were stabilized and ready for
tolerance assay. Mock induction was performed with Canton S ﬂies
(wild type).
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